The United States has the “opportunity and responsibility” to lead a global action against the hepatitis B virus (HBV) and hepatitis C virus (HCV), according to a report published by the National Academies of Sciences, Engineering, and Medicine. While there is no vaccine for HCV, new therapies do offer a cure for most patients. But eradicating HCV requires a multipronged approach: ending transmission, eliminating chronic HCV, and reducing morbidity and mortality associated with the disease. For more information on the strategies that could meet these goals, go to Federal Practitioner: http://www.fedprac.com/specialty-focus/hepatitis-c/article/can-hepatitis-b-and-c-be-eliminated/cc5f56c697746870f8da1c44dc7de26e.html.